Page last updated: 2024-10-26

donepezil and Hip Fractures

donepezil has been researched along with Hip Fractures in 3 studies

Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.

Hip Fractures: Fractures of the FEMUR HEAD; the FEMUR NECK; (FEMORAL NECK FRACTURES); the trochanters; or the inter- or subtrochanteric region. Excludes fractures of the acetabulum and fractures of the femoral shaft below the subtrochanteric region (FEMORAL FRACTURES).

Research Excerpts

ExcerptRelevanceReference
"To determine whether donepezil hydrochloride can reduce the prevalence and severity of delirium in older adults undergoing hip fracture repair."9.15Pilot randomized trial of donepezil hydrochloride for delirium after hip fracture. ( Appleton, P; Davis, RB; Marcantonio, ER; Palihnich, K, 2011)
"To determine whether donepezil hydrochloride can reduce the prevalence and severity of delirium in older adults undergoing hip fracture repair."5.15Pilot randomized trial of donepezil hydrochloride for delirium after hip fracture. ( Appleton, P; Davis, RB; Marcantonio, ER; Palihnich, K, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seitz, DP1
Gill, SS1
Gruneir, A1
Austin, PC1
Anderson, G1
Reimer, CL1
Rochon, PA1
Marcantonio, ER1
Palihnich, K1
Appleton, P1
Davis, RB1
Tamimi, I1
Ojea, T1
Sanchez-Siles, JM1
Rojas, F1
Martin, I1
Gormaz, I1
Perez, A1
Dawid-Milner, MS1
Mendez, L1
Tamimi, F1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Supporting the Health of Adults Undergoing Orthopedic Surgery During the Recovery Period[NCT00586196]Phase 216 participants (Actual)Interventional2007-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change From Baseline and MDAS Scores Over Time

Measures severity of 10 delirium symptoms items (0 not present, 1 mild, 2 moderate, 3 severe) yielding a total score of 0 to 30, with 30 most severe. (NCT00586196)
Timeframe: Baseline, hospital discharge, weeks 2, 4 and 6

,
Interventionunits on a scale (Mean)
BaselineChange at Hospital DischargeChange at Week 2Change at week 4Change at week 6
Donepezil : 5 mg Each Day for 30 Days6.31.3-0.1-1.2-0.6
Placebo : Encapsulated Cornstarch8.41.6-2.2-2.0-2.0

Percentage of Participants With Delirium Using the CAM Over Time

Confusion Assessment Method (CAM)-Measure of the presence or absence of delirium. Requires 1) acute change with fluctuating course, 2) inattention, and either 3) disorganized thinking or 4) altered level of consciousness. (NCT00586196)
Timeframe: Baseline, hospital interviews, weeks 2, 4 and 6

,
Interventionpercentage of participants (Number)
baslinehospital interviewsWeek 2week 4week 6
Donepezil : 5 mg Each Day for 30 Days1464431750
Placebo : Encapsulated Cornstarch4464434350

Trials

1 trial available for donepezil and Hip Fractures

ArticleYear
Pilot randomized trial of donepezil hydrochloride for delirium after hip fracture.
    Journal of the American Geriatrics Society, 2011, Volume: 59 Suppl 2

    Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Delirium; Donepezil; Double-Blind Method; Female

2011

Other Studies

2 other studies available for donepezil and Hip Fractures

ArticleYear
Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2011, Volume: 19, Issue:9

    Topics: Aged; Aged, 80 and over; Anesthesia, General; Cholinesterase Inhibitors; Cohort Studies; Critical Ca

2011
Acetylcholinesterase inhibitors and the risk of hip fracture in Alzheimer's disease patients: a case-control study.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2012, Volume: 27, Issue:7

    Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Alzheimer Disease; Body Mass Index; Case-Control Stud

2012